Show Notes
Melody Hartzler
Kara Siedman
In Today's Episode
In this episode of the Tables Talk Podcast, Dr. Melody Hartzler sits down with Kara Siedman, RD, CDCES, Director of Partnerships at ResBiotic, to examine how microbiome-driven physiology intersects with hormonal transitions during perimenopause and menopause.
As estrogen and progesterone fluctuate and decline, women experience predictable shifts in metabolic regulation, immune signaling, and inflammatory burden. Increasing evidence suggests these changes are tightly linked to alterations in gut microbial diversity, intestinal barrier integrity, and microbial metabolite production. This conversation explores the gut–hormone axis through a mechanistic lens, highlighting how microbiome dysfunction may amplify symptoms such as blood sugar instability, weight gain, estrogen dominance, gastrointestinal distress, and genitourinary changes.
Kara draws on clinical experience and emerging research to clarify why many hormonally driven symptoms occur in the absence of overt disease on conventional testing. The episode emphasizes perimenopause as a critical intervention window—one in which targeted dietary, lifestyle, and microbiome-supportive strategies may meaningfully influence long-term cardiometabolic and immune health.
Key Takeaways
Hormonal decline during perimenopause is closely linked to reduced microbiome diversity and resilienceEstrogen loss impacts intestinal barrier function, inflammation, and metabolic regulationThe estrobolome plays a central role in estrogen metabolism and symptom expressionMicrobiome-targeted interventions may reduce cardiometabolic risk during menopauseDiet, fiber diversity, and precision biotics are foundational tools for supporting this transitionEpisode Highlights
Hormonal Transitions & the Gut–Hormone Axis
Estrogen and progesterone fluctuations in perimenopauseBidirectional signaling between endocrine function and the microbiomeDeclining microbial diversity and reduced short-chain fatty acid productionInflammation, Metabolism, and Insulin Resistance
Metabolic endotoxemia and LPS-driven inflammationMicrobiome contributions to blood sugar dysregulation and weight gainLinks between dysbiosis, immune activation, and chronic disease riskThe Estrobolome & Estrogen Metabolism
Beta-glucuronidase activity and estrogen deconjugationMicrobial reactivation of estrogen and clinical implicationsEstrogen dominance, elimination pathways, and gut healthVaginal Microbiome & Genitourinary Health
Estrogen-dependent Lactobacillus depletionIncreased risk of UTIs and yeast infectionsGut–vaginal microbiome crosstalk and clinical considerationsClinical Interventions to Support Microbiome Resilience
Mediterranean-style dietary patterns and plant diversityFiber intake, resistant starch, prebiotics, probiotics, and postbioticsStress, sleep disruption, medications, and microbiome vulnerabilityPrecision supplementation during the menopausal transition
